Atrial Fibrillation (AF) is the most frequent arrhythmic disorder of the heart. At Ablacon, we leverage our expertise in electrophysiology, computer vision and deep learning to build a real-time high-precision AI-based diagnosis system.
We are an international team based in Lausanne (CH), Denver, CO (US) and Munich (DE) with a partner clinic in Hamburg (DE).
Total Funding: $33.5M
Funding Stage: Series B
Business Stage: Development
Market: B2G, B2B
Company Size: 26 to 50
Founded: 2015
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at Ablacon
Ablacon - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups
Ablacon - Manage Profile